CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Astria Therapeutics, Inc. - ATXS CFD

    -
    0%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 -
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.024874%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.002651%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    关键数据
    前收盘价* N/A
    开盘价* N/A
    1 年变化* N/A
    日范围* N/A
    52 周范围 2.36-16.28
    平均交易量（10 天） 239.64K
    平均交易量（3 个月) 4.84M
    市值 372.22M
    市盈率 -100.00K
    流通股 27.99M
    收入 N/A
    EPS -3.62
    股息（收益率 %） N/A
    贝塔 0.91
    下一个财报发布日期 May 10, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平倉 Change Change (%) 開倉 High Low

    Astria Therapeutics, Inc. Events

    時間（協調世界時） (UTC) 國家 事件
    No events scheduled
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 0 0 0 0 0
    总营业费用 53.503 194.976 37.435 27.088 26.371
    销售/一般/行政费用，总计 19.239 14.807 11.845 8.771 9.329
    研究与开发 34.264 180.169 25.59 18.317 17.042
    营业收入 -53.503 -194.976 -37.435 -27.088 -26.371
    利息收入（费用），非经营净值 1.724 0.122 0.236 0.845 0.325
    其他，净值 -0.055 -0.058 -0.101 -0.05 0.176
    税前净收入 -51.834 -194.912 -37.3 -26.293 -25.87
    税后净收入 -51.834 -194.912 -37.3 -26.293 -25.87
    未计算非常项目前的净收益 -51.834 -194.912 -37.3 -26.293 -25.87
    净收入 -51.834 -194.912 -37.3 -26.293 -25.87
    普通股股东可获收益 (不含非经常性项目) -51.834 -219.349 -37.3 -26.293 -25.87
    普通股股东可获收益 (含非經常性項目) -51.834 -219.349 -37.3 -26.293 -25.87
    摊薄净收入 -51.834 -219.349 -37.3 -26.293 -25.87
    摊薄后加权平均股 14.6206 8.92517 3.05864 1.86655 0.84249
    扣除特别项目的每股摊薄盈利 -3.54527 -24.5764 -12.195 -14.0864 -30.7067
    Dividends per Share - Common Stock Primary Issue
    每股正常摊薄盈利 -3.54527 -24.5764 -12.195 -14.0864 -30.7067
    收入 0
    非常规项目总计
    Total Adjustments to Net Income 0 -24.437
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    总收入 0 0 0 0 0
    总营业费用 14.29 12.386 11.449 15.378 9.508
    销售/一般/行政费用，总计 4.699 4.688 4.832 5.02 3.815
    研究与开发 9.591 7.698 6.617 10.358 5.693
    营业收入 -14.29 -12.386 -11.449 -15.378 -9.508
    其他，净值 0.009 -0.048 -0.015 -0.001 -0.016
    税前净收入 -13.263 -11.997 -11.25 -15.323 -9.491
    税后净收入 -13.263 -11.997 -11.25 -15.323 -9.491
    未计算非常项目前的净收益 -13.263 -11.997 -11.25 -15.323 -9.491
    净收入 -13.263 -11.997 -11.25 -15.323 -9.491
    普通股股东可获收益 (不含非经常性项目) -13.263 -11.997 -11.25 -15.323 -9.491
    普通股股东可获收益 (含非經常性項目) -13.263 -11.997 -11.25 -15.323 -9.491
    摊薄净收入 -13.263 -11.997 -11.25 -15.323 -9.491
    摊薄后加权平均股 18.6982 13.7424 13.017 13.017 13.0598
    扣除特别项目的每股摊薄盈利 -0.70932 -0.87299 -0.86426 -1.17716 -0.72673
    Dividends per Share - Common Stock Primary Issue 0 0 0
    每股正常摊薄盈利 -0.70932 -0.87299 -0.86426 -1.17716 -0.72673
    利息收入（费用），非经营净值 1.018 0.437 0.214 0.056 0.033
    Total Adjustments to Net Income 0 0 0 0
    • 年度
    • 每季度
    2021 2020 2019 2018 2017
    流动资产总额 127.075 46.325 38.958 38.915 17.463
    现金和短期投资 125.508 44.93 36.244 37.57 16.369
    现金等价物 1.853 22.999 5.432 5.956 16.369
    短期投资 39 20 26.345 22.276 0
    Prepaid Expenses 1.446 1.274 2.237 1.345 1.094
    Total Assets 127.514 47.456 41.78 39.169 17.897
    Property/Plant/Equipment, Total - Net 0.394 0.966 2.349 0.056 0.321
    Property/Plant/Equipment, Total - Gross 0.377
    Accumulated Depreciation, Total -0.321
    Other Long Term Assets, Total 0.045 0.165 0.473 0.198 0.113
    Total Current Liabilities 5.203 6.39 5.032 4.171 6.016
    Accounts Payable 1.557 1.544 1.197 1.408 0.773
    Accrued Expenses 3.646 4.846 3.835 2.763 2.432
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 2.479
    Total Liabilities 5.203 6.787 6.06 4.227 6.105
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt 0
    Other Liabilities, Total 0 0.397 1.028 0.056 0.089
    Total Equity 122.311 40.669 35.72 34.942 11.792
    Common Stock 0.013 0.02 0.012 0.007 0.024
    Additional Paid-In Capital 481.709 301.546 259.305 232.243 183.202
    Retained Earnings (Accumulated Deficit) -455.809 -260.897 -223.597 -197.304 -171.434
    Other Equity, Total 0 0 -0.004 0
    Total Liabilities & Shareholders’ Equity 127.514 47.456 41.78 39.169 17.897
    Total Common Shares Outstanding 13.017 3.34746 2.07227 0.11903 0.3941
    Other Current Liabilities, Total 0 0.332
    Preferred Stock - Non Redeemable, Net 96.398 0 0 0
    Cash 84.655 1.931 4.467 9.338
    Other Current Assets, Total 0.121 0.121 0.477
    Total Preferred Shares Outstanding 0.03146
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    流动资产总额 114.221 127.075 134.522 140.052 147.684
    现金和短期投资 112.816 125.508 131.777 139.52 146.92
    现金等价物 46.687 86.508 131.777 139.52 146.92
    短期投资 66.129 39 0 0 0
    Prepaid Expenses 1.121 1.446 2.624 0.411 0.643
    Other Current Assets, Total 0.284 0.121 0.121 0.121 0.121
    Total Assets 114.653 127.514 135.129 140.945 148.74
    Property/Plant/Equipment, Total - Net 0.228 0.394 0.557 0.717 0.874
    Other Long Term Assets, Total 0.204 0.045 0.05 0.176 0.182
    Total Current Liabilities 4.967 5.203 4.7 3.988 4.406
    Accounts Payable 0.931 1.557 0.574 0.619 1.809
    Accrued Expenses 4.036 3.646 4.126 3.369 2.597
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 4.967 5.203 4.7 4.046 9.004
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 0 0 0.058 4.598
    Total Equity 109.686 122.311 130.429 136.899 139.736
    Preferred Stock - Non Redeemable, Net 96.398 96.398 96.398 99.77 240.881
    Common Stock 0.013 0.013 0.013 0.077 0.023
    Additional Paid-In Capital 484.46 481.709 480.336 475.499 329.813
    Retained Earnings (Accumulated Deficit) -471.132 -455.809 -446.318 -438.447 -430.981
    Total Liabilities & Shareholders’ Equity 114.653 127.514 135.129 140.945 148.74
    Total Common Shares Outstanding 13.017 13.017 13.0095 12.8248 3.90283
    Total Preferred Shares Outstanding 0.03146 0.03146 0.03146 0.03255
    Other Equity, Total -0.053 0
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -51.834 -194.912 -37.3 -26.293 -25.87
    经营活动产生的现金 -43.533 -30.151 -32.485 -26.569 -23.465
    经营活动产生的现金 0.026 0.119
    非现金物品 5.654 168.066 1.448 1.568 1.524
    已付现金利息 0 0.079
    营运资金的变化 2.647 -3.305 3.367 -1.87 0.762
    投资活动产生的现金 -167.129 -12.555 6.3 -4.082 -21.905
    资本支出 -0.091 -0.021 -0.033 -0.012 0
    其他投资现金流量项目，总计 -167.038 -12.534 6.333 -4.07 -21.905
    融资活动产生的现金 144.721 104.284 40.86 25.62 44.295
    股票的发行（报废），净额 144.721 104.284 40.86 25.62 47.143
    债务的发行（退还），净额 0 -2.848
    现金净变化 -65.941 61.578 14.675 -5.031 -1.075
    融资现金流项目
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Net income/Starting Line -51.834 -38.571 -26.574 -15.323 -194.912
    Cash From Operating Activities -43.533 -32.869 -22.62 -12.559 -30.151
    Non-Cash Items 5.654 5.15 3.947 2.672 168.066
    Changes in Working Capital 2.647 0.552 0.007 0.092 -3.305
    Cash From Investing Activities -167.129 -31.949 -33.899 -27.099 -12.555
    Capital Expenditures -0.091 -0.06 -0.002 0 -0.021
    Other Investing Cash Flow Items, Total -167.038 -31.889 -33.897 -27.099 -12.534
    Cash From Financing Activities 144.721 24.324 0 0 104.284
    Issuance (Retirement) of Stock, Net 144.721 24.324 0 0 104.284
    Net Change in Cash -65.941 -40.494 -56.519 -39.658 61.578
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Fidelity Management & Research Company LLC Investment Advisor 11.9754 3351514 2974069 2022-12-31 LOW
    Perceptive Advisors LLC Private Equity 7.8232 2189462 908265 2022-12-31 MED
    Fairmount Funds Management LLC Hedge Fund 6.7939 1901397 989661 2022-12-31 HIGH
    Deep Track Capital LP Hedge Fund 6.4907 1816531 1816531 2022-12-31 MED
    Vivo Capital, LLC Venture Capital 6.0071 1681199 681199 2022-12-31 MED
    Cormorant Asset Management, LP Hedge Fund 5.8957 1650000 450000 2022-12-31 MED
    Altium Capital Management LP Investment Advisor/Hedge Fund 4.8429 1355372 910372 2022-12-31 HIGH
    Driehaus Capital Management, LLC Investment Advisor/Hedge Fund 4.7784 1337315 680954 2022-12-31 MED
    Logos Global Management LLC Investment Advisor 3.0906 864960 864960 2022-12-31 HIGH
    Ikarian Capital LLC Hedge Fund 2.4125 675176 -24264 2022-12-31 HIGH
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.338 654326 123173 2022-12-31 LOW
    Rosalind Advisors, Inc. Hedge Fund 2.3348 653438 653438 2021-12-31 LOW
    Tri Locum Partners LP Hedge Fund 2.3273 651330 19751 2022-12-31 HIGH
    Affinity Asset Advisors LLC Hedge Fund 1.6882 472482 72439 2022-12-31 HIGH
    Sphera Funds Management Ltd. Hedge Fund 1.677 469340 469340 2022-12-31 MED
    Ghost Tree Capital, LLC Hedge Fund 1.6079 450000 -50000 2022-12-31 HIGH
    Violin (Jonathan) Individual Investor 0.9409 263321 0 2022-04-13 LOW
    Opaleye Management Inc. Hedge Fund 0.9351 261703 128203 2022-12-31 MED
    Medical Strategy GmbH Investment Advisor 0.9026 252605 -18814 2022-09-30 LOW
    Point72 Asset Management, L.P. Hedge Fund 0.804 225000 225000 2022-12-31 HIGH

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    500K+

    交易者

    92K+

    每月活跃客户

    $53M+

    每月投资额

    $30M+

    每月提取金额

    交易計算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    貿易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投資
    交易規模（槓桿 x 投資）：
    開倉

    平倉

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/失利

    Astria Therapeutics, Inc. Company profile

    关于 Astria Therapeutics Inc.

    Astria Therapeutics公司，前身为Catabasis Pharmaceuticals公司，是一家生物制药公司。 该公司专注于为受罕见和利基过敏性和免疫性疾病影响的患者和家庭开发治疗方法。 其主导项目STAR-0215正处于临床前开发阶段，用于治疗遗传性血管性水肿（HAE）。 HAE是一种罕见的遗传性疾病，其特点是严重的、反复的、不可预测的、痛苦的、有时危及生命的面部、四肢、腹部和气道肿胀。 STAR-0215是一种血浆卡利克蛋白的单克隆抗体抑制剂，旨在为HAE提供长效的攻击预防。

    Industry: Bio Therapeutic Drugs

    75 State Street
    Suite 1400
    BOSTON
    MASSACHUSETTS 02109
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    多头隔夜费 -0.0156%
    空头隔夜费 -0.0063%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    BTC/USD

    28,383.05 Price
    -0.380% 1D Chg, %
    多头隔夜费 -0.0616%
    空头隔夜费 0.0137%
    隔夜费时间 21:00 (UTC)
    价差 60.00

    Natural Gas

    2.20 Price
    +3.540% 1D Chg, %
    多头隔夜费 -0.4092%
    空头隔夜费 0.3873%
    隔夜费时间 21:00 (UTC)
    价差 0.005

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    多头隔夜费 -0.0185%
    空头隔夜费 0.0102%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    还在找一位您可以信任的经纪商吗？

    加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易